For example, in endometrial cancers, mutations in CTNNB1 frequently co-occur with mutations in PIK3CA, PTEN, and ARID1A, particularly in high-grade endometrioid carcinomas [96]. This evidence concerns the gene ARID1A and endometrioid adenocarcinoma.